Brendan Smith
Stock Analyst at TD Cowen
(1.99)
# 3,140
Out of 5,090 analysts
9
Total ratings
50%
Success rate
6.15%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Maintains: Hold | $8 → $7 | $6.84 | +2.41% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $281.77 | +24.21% | 1 | Oct 29, 2025 | |
| SLP Simulations Plus | Initiates: Hold | $16 | $20.46 | -21.80% | 1 | Sep 30, 2025 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $3 → $10 | $9.21 | +8.58% | 1 | Sep 20, 2024 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $59 → $65 | $63.10 | +3.02% | 2 | Aug 7, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $64.67 | - | 1 | Jul 21, 2023 | |
| DNLI Denali Therapeutics | Initiates: Outperform | n/a | $20.30 | - | 1 | Dec 5, 2022 |
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $6.84
Upside: +2.41%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $281.77
Upside: +24.21%
Simulations Plus
Sep 30, 2025
Initiates: Hold
Price Target: $16
Current: $20.46
Upside: -21.80%
Ginkgo Bioworks Holdings
Sep 20, 2024
Maintains: Buy
Price Target: $3 → $10
Current: $9.21
Upside: +8.58%
Halozyme Therapeutics
Aug 7, 2024
Maintains: Buy
Price Target: $59 → $65
Current: $63.10
Upside: +3.02%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $64.67
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $20.30
Upside: -